ABALOS
Live / Registered — Registered (as of 14 Jun 2022)
What this means for you
Registered since 14 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90075873
- Registration number
- 6756581
- Mark type
- Stylized text
- Filed
- 27 Jul 2020
- Published for opposition
- 29 Mar 2022
- Registered
- 14 Jun 2022
- Attorney of record
- Michael A Whittaker
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, medical and veterinary preparations for use in treating cancer; pharmaceutical, medical and veterinary preparations containing arenaviruses for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a lymphocytic choriomeningitis virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Ippy virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Lassa virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Mobala virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Mopeia virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Allpaahuayo virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Amapari virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Bear Canyon virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Chapare virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Cupixi virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Flexal virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Guanarito virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Junin virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Latino virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Machupo virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Oliveros virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Parana virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Pichinde virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Pirital virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Sabia virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Tacaribe virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Tamiami virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Whitewara Arroyo virus for use in treating cancer; cancer drugs, namely, pharmaceutical preparations for use in treating cancer; immuno-oncology drugs, namely, pharmaceutical preparations for use in treating cancer; vaccines
Owner
- Abalos Therapeutics GmbH, Duesseldorf, DE
- Abalos Therapeutics GmbH, Duesseldorf, DE
- Abalos Therapeutics GmbH, Essen, DE
Prosecution history
- 14 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 28 Apr 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Apr 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Mar 2022 — PUBLISHED FOR OPPOSITION
- 09 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Feb 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 18 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jan 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jan 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jan 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 30 Jul 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 30 Jul 2021 — FINAL REFUSAL E-MAILED